In a new lawsuit over Medtronic’s bone-growth product Infuse, health insurer Humana said that the med-tech company conspired with physicians to promote the drug’s use. The Wall Street Journal reports on the lawsuit, filed last week, that accuses Fridley-based Medtronic (NYSE: MDT) of violating federal racketeering laws for payments of $210 million to physicians, who then advocated the use of Infuse in neck and spine surgeries that hadn’t been approved by the U.S. Food and Drug Administration. Humana (NYSE: HUM) said that because of the physicians’ efforts, it paid for procedures that it otherwise wouldn’t have.
Help employers find you! Check out all the jobs and post your resume.
